Previous studies have shown that LAPTM4B polymorphisms are associated with increased risk for gallbladder carcinoma, gastric cancer, colon cancer and liver cancer in Chinese patients [23]–[27]. This evidence concerns the gene LAPTM4B and malignant colon neoplasm.